Page 61 - Ip Group News Today

  IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a st...

LaingBuisson News Oxford Nanopore Technologies has raised £195m (US$273m) in new capital in a private transaction. Some £125 million of the investment comes from new investors Temasek, Wellington Management, M&G Investments and Nikon. In addition, existing shareholders invested £70 million. Oxford Nanopore was founded in 2005 to develop a disruptive, electronic, single-molecule sensing system based on nanopore science. The private company has raised £808m in a series of funding roun...

  IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a st...

  IP Group plc (LSE: IPO) ("IP Group" or "the Company" or "the Group"), the developer of intellectual property-based businesses, announces that it has published its Annual Report and Accounts for the year ended 31 December 2020.   In compliance with Listing Rule 9.6.3, a copy of the following documents will shortly be available for inspection at www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism .   - ...

Athenex Inc (NASDAQ: ATNX) shares have risen during premarket trading in reaction to acquiring Kuur Therapeutics Inc, a portfolio ...

5 May 2021 | 08:23am StockMarketWire.com - Intellectual property-based businesses developer IP Group said its portfolio companies Inivata and Kuur Therapeutics were acquired by NeoGenomics and Athenex, respectively. IP Group would receive approximately $91 million in cash or, potentially, NeoGenomics stock, for the sale of the Inivata. For the sale of Kuur Therapeutics, IP Group would receive £30 million in Athenex stock and is eligible to receive up to a further £52 million in milestone pa...

4 May 2021 | 07:31am StockMarketWire.com - Intellectual property investor IP said its portfolio company Oxford Nanopore Technologies had raised £195 million in new capital. IP committed £18.7 million to the funding round. Following completion of the round, IP Group held a 14.5% stake in Oxford Nanopore, valued at £359 million. Story provided by StockMarketWire.com Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Latest share price and company details:

Oxford Nanopore raises £195m ahead of London listing Oxford Nanopore has raised £195m in fresh funding ahead of its planned IPO in London later this year, it said this morning. The company has helped to track coronavirus mutations in the past year, which has made it somewhat of a darling of UK genetics work. The Oxfordshire-based scale-up said £125m of investment came from new investors Temasek, Wellington Management, M&G Management and Nikon, with existing investors contri...

Mission Therapeutics to Participate in Upcoming SVB Leerink Biopharma Private Company Connect Event Mission Therapeutics ("Mission"), a drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes (DUBs), today announced that members of its management will be attending the upcoming SVB Leerink Biopharma Private Company Connect Event. The event, which will take place virtually on 6-7 May 2021, is intended to bring together private companies with instituti...

REPUBLIC OF SOUTH AFRICA OR JAPAN. NEITHER THIS ANNOUNCEMENT NOR ANYTHING CONTAINED HEREIN SHALL FORM THE BASIS OF, OR BE RELIED UPON IN CONNECTION WITH, ANY OFFER OR COMMITMENT WHATSOEVER IN ANY JURISDICTION.   THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU AS IT FORMS PART OF THE LAW OF ENGLAND AND WALES BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. IN ADDITION, MARKET SOUNDINGS WERE TAKEN IN RESPECT OF THE MATTERS CONTAINED ...